test directorySearch Results
Click here to search again.
Test Name:
NMP22®
- SBMF No:
44630 - Performance Lab Name:
ARUP Laboratories - Test Mnemonic:
U NMP22 - ABN:
Not required - CPT Code:
86316 - LOINC Code:
31134-0 - Ref Lab Test No:
0080281 - Also Known As:
Nuclear Matrix Protein
Bladder Tumor Associated Antigen - Spec Type:
Urine, Stabilized - Spec Container:
NMP22® Urine Stabilizer Vial (contact lab) - Pref Vol:
5.0 mL - Spec Collect:
Single void of urine
Collect between midnight and noon - Spec Process:
Immediately following collection, transfer 5 mL urine to NMP22® Urine Stabilizer Vial and freeze
(Stabilized specimen should be blue/green in color) - Spec Store Transport:
Frozen - Spec Stability:
48 hours room temperature (20-30°C)
72 hours refrigerated (2-8°C)
1 month frozen (-20°C) – Do not use frost-free units that undergo repeated freeze/thaw cycles - Spec Reject:
Urine not stabilized in NMP22® Urine Stabilizer Vial - Methodology:
Quantitative Enzyme Immunoassay (EIA) - Clinical Significance:
Refer to:
- Reference Range:
0.0-10.0 U/mL
Interpretive Data:
The NMP22® assay is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT). It is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT.Values obtained with different assay methods should not be used interchangeably. ARUP uses the Matritech NMP22® Test Kit which is an enzyme immunoassay (EIA) method.
- Day Run:
Thu - Time Reported:
2-9 days - Test Type:
URINE
